sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> infectious disease therapeutics market

report

Infectious Disease Therapeutics Market, by Disease Type (HIV, Influenza, TB, Malaria, Hepatitis, HPV) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC374 September 2017 100+ FREE 10% CUSTOMIZATION

Several microorganisms such as fungi, parasites, bacteria, viruses and others cause various infectious diseases such as malaria, influenza, HIV and tuberculosis. It is the mostly occurs by inadequate personal hygiene and poor sanitation. Such diseases are being spread either through indirect or direct contact. Anti-infective drugs are mainly used for inhibiting or destroying the market growth of diseases causing agents. Antifungal, antiviral, antibacterial and anti-parasitic drugs are few of the anti-infective drugs.

The report on the global Infectious disease therapeutics market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Private organizations and government heavily invest in the healthcare industry in order to diagnose, prevent, and treat infectious diseases; increasing investments done in the drug development for treating infectious diseases, and growing no of awareness initiatives for taken for these conditions are anticipated to fuel the global market for infectious disease therapeutics during the forecast period.
  • Additionally, growing no. of patent expired and generic drugs entry in the global market for infectious disease therapeutics are projected to increase the market demand for infectious disease therapeutics owing to low prices. Also, accessibility of diagnosis & treatment reimbursement of such infections is anticipated to boost the market growth of infectious disease therapeutics.
  • However, lower penetration rate and large no. of available counterfeit drugs are anticipated to hamper the market growth of infectious disease therapeutics over the forecast period.

Regionally, the global infectious disease therapeutics market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. Among these regions, North America is the leader in global infectious disease therapeutics market with maximum no. of market share in past few years. Availability of huge no. of manufacturers, positive reimbursement scenario, and growing expenditure on healthcare are key factors that are responsible for maximum market share held in this region. However, Asia Pacific region is likely to expand with maximum market share in the years to come.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s infectious disease therapeutics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the infectious disease therapeutics market by the following segments:

  • Infectious Disease Therapeutics Market, by Disease Type
    • HIV
    • Influenza
    • TB
    • Malaria
    • Hepatitis
    • HPV

KEY MARKET PLAYERS

Key players in the infectious disease therapeutics market include:

  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Janssen Pharmaceutical
  • F. Hoffmann-La Roche AG
  • BioCryst Pharmaceuticals, Inc
  • Boehringer Ingelheim GmbH
  • Novartis International AG
  • Merck & Co., Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Home Healthcare Software Market, by Products (Hospice Solution Software, Telehealth Solution Software, Clinical Management Systems Software, Agency Software and Others), Service (Home Healthcare Software Services And Non-Clinical Home Healthcare Software Services), End-User (Rehabilitation Centres, Homecare Agencies, Hospice Care And Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. INFECTIOUS DISEASE THERAPEUTICS MARKET, BY DISEASE TYPE
    1. Segment Share
    2. By Disease Type
      1. HIV
      2. Influenza
      3. TB
      4. Malaria
      5. Hepatitis
      6. HPV
  6. INFECTIOUS DISEASE THERAPEUTICS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Disease Type
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Disease Type
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Disease Type
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Disease Type
  7. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  8. KEY MARKET PLAYERS
    1. Gilead Sciences, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. GlaxoSmithKline plc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Janssen Pharmaceutical
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. F. Hoffmann-La Roche AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. BioCryst Pharmaceuticals, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Boehringer Ingelheim GmbH
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Novartis International AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
  9. SCALAR 360 DEGREE MARKET PERSPECTIVE
  10. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us